These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of chlorpromazine on experimental delayed cerebral vasospasm. Nakano M; Tani E; Fukumori T; Yokota M J Neurosurg; 1984 Nov; 61(5):857-63. PubMed ID: 6491731 [TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous ethanol on cerebral vasospasm produced by subarachnoid blood. Barry KJ; Scott RM Stroke; 1979; 10(5):535-7. PubMed ID: 505494 [TBL] [Abstract][Full Text] [Related]
4. Control of cerebral vasospasm by parenteral phenoxybenzamine. Flamm ES; Yasargil MG; Ransohoff J Stroke; 1972; 3(4):421-6. PubMed ID: 4403117 [No Abstract] [Full Text] [Related]
5. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition. Gavras H; Andrews P; Papadakis N J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740 [TBL] [Abstract][Full Text] [Related]
7. Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93. Handa Y; Yoneda S; Koyama T; Matsuda M; Handa H Surg Neurol; 1975 Apr; 3(4):195-9. PubMed ID: 1145417 [TBL] [Abstract][Full Text] [Related]
8. Cerebral aterial spasm. I. Adrenergic mechanism in experimental cerebral vasospasm. Morooka H Acta Med Okayama; 1978 Apr; 32(1):23-37. PubMed ID: 148833 [TBL] [Abstract][Full Text] [Related]
9. Observations on the effects of intrathecal papaverine in experimental vasospasm. Ogata M; Marshall BM; Lougheed WM J Neurosurg; 1973 Jan; 38(1):20-5. PubMed ID: 4629882 [No Abstract] [Full Text] [Related]
10. Etiology and treatment of vasospasm following subarachnoid hemorrhage. Nonaka T; Watanabe S; Chigasaki H; Miyaoka M; Ishii S Neurol Med Chir (Tokyo); 1979 Jan; 19(1):53-60. PubMed ID: 84356 [No Abstract] [Full Text] [Related]
11. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855 [TBL] [Abstract][Full Text] [Related]
16. Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Kwan AL; Lin CL; Yanamoto H; Howng SL; Kassell NF; Lee KS Neurosurgery; 1998 Feb; 42(2):347-50; discussion 350-1. PubMed ID: 9482186 [TBL] [Abstract][Full Text] [Related]
17. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Arthur AS; Fergus AH; Lanzino G; Mathys J; Kassell NF; Lee KS Neurosurgery; 1997 Dec; 41(6):1385-91; discussion 1391-2. PubMed ID: 9402590 [TBL] [Abstract][Full Text] [Related]
18. Cerebral vasospasm following subarachnoid hemorrhage--experimental and clinical studies. Ohmoto T; Yoshioka J; Shibata K; Morooka H; Matsumoto Y; Nishimoto A Neurol Med Chir (Tokyo); 1979 Jan; 19(1):73-81. PubMed ID: 84358 [No Abstract] [Full Text] [Related]
19. [Cerebral vasospasm caused by subarachnoid hemorrhage and its management, with special reference to the vasospastic effects of oxyhemoglobin]. Sakurai Y; Sonobe M; Endo S; Suzuki J Nihon Rinsho; 1978; 36(3):550-4. PubMed ID: 650931 [No Abstract] [Full Text] [Related]
20. Attenuation of basilar artery spasm after experimental subarachnoid hemorrhage in rabbit by potassium channel activator cromakalim--a preliminary result. Kwan AL; Lin CL; Howng SL Kaohsiung J Med Sci; 1999 May; 15(5):268-73. PubMed ID: 10375869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]